nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—Fibrosis—Lomustine—brain cancer	0.03	0.0714	CcSEcCtD
Alprostadil—PTGIR—endothelium—brain cancer	0.0174	0.0658	CbGeAlD
Alprostadil—PTGIR—blood vessel—brain cancer	0.016	0.0607	CbGeAlD
Alprostadil—PTGIR—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.0158	0.0516	CbGpPWpGaD
Alprostadil—PTGIR—hindbrain—brain cancer	0.0153	0.0579	CbGeAlD
Alprostadil—Fibrosis—Hydroxyurea—brain cancer	0.0148	0.0351	CcSEcCtD
Alprostadil—SLCO2B1—ganglion—brain cancer	0.0126	0.0478	CbGeAlD
Alprostadil—Fibrosis—Carmustine—brain cancer	0.0119	0.0284	CcSEcCtD
Alprostadil—Hyperaemia—Carmustine—brain cancer	0.0113	0.0268	CcSEcCtD
Alprostadil—PTGIR—brainstem—brain cancer	0.00877	0.0332	CbGeAlD
Alprostadil—Epoprostenol—CYP2C9—brain cancer	0.00859	1	CrCbGaD
Alprostadil—PTGER2—Ovarian Infertility Genes—ESR2—brain cancer	0.00853	0.0278	CbGpPWpGaD
Alprostadil—Haemorrhage intracranial—Temozolomide—brain cancer	0.00803	0.0191	CcSEcCtD
Alprostadil—PTGER1—endocrine gland—brain cancer	0.00795	0.0301	CbGeAlD
Alprostadil—PTGER1—head—brain cancer	0.00784	0.0297	CbGeAlD
Alprostadil—PTGIR—telencephalon—brain cancer	0.00778	0.0294	CbGeAlD
Alprostadil—PTGER1—central nervous system—brain cancer	0.00716	0.0271	CbGeAlD
Alprostadil—PTGIR—Thromboxane A2 receptor signaling—TGM2—brain cancer	0.00714	0.0233	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—TSC22D1—brain cancer	0.00699	0.0228	CbGpPWpGaD
Alprostadil—PTGIR—gonad—brain cancer	0.0065	0.0246	CbGeAlD
Alprostadil—Lethargy—Lomustine—brain cancer	0.00636	0.0151	CcSEcCtD
Alprostadil—ABCC5—telencephalon—brain cancer	0.00622	0.0235	CbGeAlD
Alprostadil—Cerebral haemorrhage—Carmustine—brain cancer	0.00616	0.0146	CcSEcCtD
Alprostadil—Cerebral haemorrhage—Temozolomide—brain cancer	0.00595	0.0141	CcSEcCtD
Alprostadil—SLCO3A1—gonad—brain cancer	0.00573	0.0217	CbGeAlD
Alprostadil—SLCO3A1—pituitary gland—brain cancer	0.00559	0.0212	CbGeAlD
Alprostadil—SLCO2A1—pituitary gland—brain cancer	0.00554	0.021	CbGeAlD
Alprostadil—PTGIR—spinal cord—brain cancer	0.00545	0.0206	CbGeAlD
Alprostadil—SLCO3A1—medulla oblongata—brain cancer	0.0054	0.0204	CbGeAlD
Alprostadil—PTGER2—Ovarian Infertility Genes—CDK4—brain cancer	0.00519	0.0169	CbGpPWpGaD
Alprostadil—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00511	0.0167	CbGpPWpGaD
Alprostadil—ABCC5—pituitary gland—brain cancer	0.00507	0.0192	CbGeAlD
Alprostadil—SLCO3A1—midbrain—brain cancer	0.00493	0.0187	CbGeAlD
Alprostadil—PTGIR—endocrine gland—brain cancer	0.00491	0.0186	CbGeAlD
Alprostadil—Burning sensation—Carmustine—brain cancer	0.00491	0.0117	CcSEcCtD
Alprostadil—ABCC5—medulla oblongata—brain cancer	0.00489	0.0185	CbGeAlD
Alprostadil—SLCO2B1—telencephalon—brain cancer	0.00487	0.0184	CbGeAlD
Alprostadil—PTGIR—head—brain cancer	0.00485	0.0183	CbGeAlD
Alprostadil—SLCO3A1—spinal cord—brain cancer	0.00481	0.0182	CbGeAlD
Alprostadil—Renal failure—Lomustine—brain cancer	0.00472	0.0112	CcSEcCtD
Alprostadil—Influenza-like symptoms—Temozolomide—brain cancer	0.00461	0.011	CcSEcCtD
Alprostadil—ABCC5—midbrain—brain cancer	0.00447	0.0169	CbGeAlD
Alprostadil—PTGIR—central nervous system—brain cancer	0.00442	0.0167	CbGeAlD
Alprostadil—SLCO3A1—endocrine gland—brain cancer	0.00433	0.0164	CbGeAlD
Alprostadil—Haemoglobin—Lomustine—brain cancer	0.00433	0.0103	CcSEcCtD
Alprostadil—PTGIR—cerebellum—brain cancer	0.00432	0.0164	CbGeAlD
Alprostadil—Haemorrhage—Lomustine—brain cancer	0.00431	0.0102	CcSEcCtD
Alprostadil—SLCO2A1—endocrine gland—brain cancer	0.00429	0.0162	CbGeAlD
Alprostadil—SLCO3A1—head—brain cancer	0.00428	0.0162	CbGeAlD
Alprostadil—SLCO2A1—head—brain cancer	0.00424	0.016	CbGeAlD
Alprostadil—Injection site pain—Carmustine—brain cancer	0.00417	0.00993	CcSEcCtD
Alprostadil—Visual impairment—Lomustine—brain cancer	0.00415	0.00987	CcSEcCtD
Alprostadil—Lethargy—Procarbazine—brain cancer	0.00404	0.00959	CcSEcCtD
Alprostadil—SLCO3A1—central nervous system—brain cancer	0.0039	0.0148	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—brain cancer	0.00387	0.0146	CbGeAlD
Alprostadil—Accidental injury—Carmustine—brain cancer	0.00385	0.00916	CcSEcCtD
Alprostadil—SLCO2B1—medulla oblongata—brain cancer	0.00383	0.0145	CbGeAlD
Alprostadil—SLCO3A1—cerebellum—brain cancer	0.00382	0.0144	CbGeAlD
Alprostadil—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00362	0.00861	CcSEcCtD
Alprostadil—PTGIR—brain—brain cancer	0.00351	0.0133	CbGeAlD
Alprostadil—Infection—Carboplatin—brain cancer	0.00348	0.00827	CcSEcCtD
Alprostadil—ABCC5—cerebellum—brain cancer	0.00346	0.0131	CbGeAlD
Alprostadil—SLCO2B1—spinal cord—brain cancer	0.00341	0.0129	CbGeAlD
Alprostadil—PTGIR—Platelet homeostasis—TRPC6—brain cancer	0.0034	0.0111	CbGpPWpGaD
Alprostadil—Injection site reaction—Carmustine—brain cancer	0.00339	0.00806	CcSEcCtD
Alprostadil—Sweating increased—Procarbazine—brain cancer	0.00333	0.00792	CcSEcCtD
Alprostadil—Influenza like illness—Temozolomide—brain cancer	0.0032	0.00761	CcSEcCtD
Alprostadil—Numbness—Etoposide—brain cancer	0.00318	0.00756	CcSEcCtD
Alprostadil—Pollakiuria—Procarbazine—brain cancer	0.00316	0.00751	CcSEcCtD
Alprostadil—Apnoea—Etoposide—brain cancer	0.00311	0.00739	CcSEcCtD
Alprostadil—SLCO3A1—brain—brain cancer	0.0031	0.0117	CbGeAlD
Alprostadil—SLCO2B1—endocrine gland—brain cancer	0.00307	0.0116	CbGeAlD
Alprostadil—SLCO2A1—brain—brain cancer	0.00307	0.0116	CbGeAlD
Alprostadil—Sensory loss—Etoposide—brain cancer	0.00304	0.00723	CcSEcCtD
Alprostadil—Infection—Lomustine—brain cancer	0.00304	0.00723	CcSEcCtD
Alprostadil—SLCO2B1—head—brain cancer	0.00303	0.0115	CbGeAlD
Alprostadil—Thrombocytopenia—Lomustine—brain cancer	0.003	0.00713	CcSEcCtD
Alprostadil—Pain—Carboplatin—brain cancer	0.00299	0.00711	CcSEcCtD
Alprostadil—Abnormal vision—Carmustine—brain cancer	0.00297	0.00707	CcSEcCtD
Alprostadil—Sepsis—Carmustine—brain cancer	0.00296	0.00703	CcSEcCtD
Alprostadil—Haematuria—Procarbazine—brain cancer	0.00291	0.00691	CcSEcCtD
Alprostadil—Abnormal vision—Temozolomide—brain cancer	0.00287	0.00683	CcSEcCtD
Alprostadil—Blood creatinine increased—Hydroxyurea—brain cancer	0.00287	0.00682	CcSEcCtD
Alprostadil—Diabetes mellitus—Carmustine—brain cancer	0.00284	0.00676	CcSEcCtD
Alprostadil—ABCC5—brain—brain cancer	0.00281	0.0106	CbGeAlD
Alprostadil—Swelling—Carmustine—brain cancer	0.0028	0.00667	CcSEcCtD
Alprostadil—SLCO2B1—central nervous system—brain cancer	0.00277	0.0105	CbGeAlD
Alprostadil—Body temperature increased—Carboplatin—brain cancer	0.00277	0.00658	CcSEcCtD
Alprostadil—Haemoglobin—Procarbazine—brain cancer	0.00275	0.00654	CcSEcCtD
Alprostadil—Haemorrhage—Procarbazine—brain cancer	0.00274	0.0065	CcSEcCtD
Alprostadil—ABCC4—endocrine gland—brain cancer	0.00272	0.0103	CbGeAlD
Alprostadil—SLCO2B1—cerebellum—brain cancer	0.00271	0.0102	CbGeAlD
Alprostadil—Injury—Carmustine—brain cancer	0.00269	0.0064	CcSEcCtD
Alprostadil—ABCC4—head—brain cancer	0.00269	0.0102	CbGeAlD
Alprostadil—Nasal congestion—Temozolomide—brain cancer	0.00262	0.00624	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—PTCH2—brain cancer	0.00254	0.00829	CbGpPWpGaD
Alprostadil—Flushing—Procarbazine—brain cancer	0.00254	0.00604	CcSEcCtD
Alprostadil—ABCC4—central nervous system—brain cancer	0.00245	0.00927	CbGeAlD
Alprostadil—Body temperature increased—Lomustine—brain cancer	0.00242	0.00575	CcSEcCtD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00234	0.00763	CbGpPWpGaD
Alprostadil—Nervousness—Procarbazine—brain cancer	0.00231	0.0055	CcSEcCtD
Alprostadil—Sepsis—Etoposide—brain cancer	0.00229	0.00544	CcSEcCtD
Alprostadil—Hypokalaemia—Carmustine—brain cancer	0.00225	0.00535	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—OR14C36—brain cancer	0.00223	0.00727	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—OR4C12—brain cancer	0.00223	0.00727	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00222	0.00724	CbGpPWpGaD
Alprostadil—Anaemia—Procarbazine—brain cancer	0.0022	0.00523	CcSEcCtD
Alprostadil—SLCO2B1—brain—brain cancer	0.0022	0.00831	CbGeAlD
Alprostadil—Hypokalaemia—Temozolomide—brain cancer	0.00218	0.00517	CcSEcCtD
Alprostadil—Swelling—Etoposide—brain cancer	0.00217	0.00516	CcSEcCtD
Alprostadil—Syncope—Procarbazine—brain cancer	0.00214	0.00508	CcSEcCtD
Alprostadil—Haemoglobin—Hydroxyurea—brain cancer	0.00213	0.00506	CcSEcCtD
Alprostadil—Haemorrhage—Hydroxyurea—brain cancer	0.00212	0.00503	CcSEcCtD
Alprostadil—PTGIR—Thromboxane A2 receptor signaling—PIK3CG—brain cancer	0.00211	0.00689	CbGpPWpGaD
Alprostadil—Cardiac failure congestive—Etoposide—brain cancer	0.00211	0.00502	CcSEcCtD
Alprostadil—Loss of consciousness—Procarbazine—brain cancer	0.00209	0.00498	CcSEcCtD
Alprostadil—Cough—Procarbazine—brain cancer	0.00208	0.00494	CcSEcCtD
Alprostadil—Convulsion—Procarbazine—brain cancer	0.00206	0.00491	CcSEcCtD
Alprostadil—Hypertension—Procarbazine—brain cancer	0.00206	0.00489	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—OR4C12—brain cancer	0.00202	0.0066	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—OR14C36—brain cancer	0.00202	0.0066	CbGpPWpGaD
Alprostadil—Sweating increased—Temozolomide—brain cancer	0.00201	0.00479	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—MPL—brain cancer	0.00199	0.0065	CbGpPWpGaD
Alprostadil—Bronchitis—Temozolomide—brain cancer	0.00199	0.00473	CcSEcCtD
Alprostadil—Dry mouth—Procarbazine—brain cancer	0.00198	0.00471	CcSEcCtD
Alprostadil—ABCC4—brain—brain cancer	0.00195	0.00736	CbGeAlD
Alprostadil—Oedema—Procarbazine—brain cancer	0.00194	0.00462	CcSEcCtD
Alprostadil—Infection—Procarbazine—brain cancer	0.00193	0.00459	CcSEcCtD
Alprostadil—Hyperglycaemia—Carmustine—brain cancer	0.00193	0.00459	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Temozolomide—brain cancer	0.00192	0.00457	CcSEcCtD
Alprostadil—Shock—Procarbazine—brain cancer	0.00191	0.00455	CcSEcCtD
Alprostadil—Pollakiuria—Temozolomide—brain cancer	0.00191	0.00454	CcSEcCtD
Alprostadil—Thrombocytopenia—Procarbazine—brain cancer	0.0019	0.00452	CcSEcCtD
Alprostadil—Tachycardia—Procarbazine—brain cancer	0.0019	0.00451	CcSEcCtD
Alprostadil—Hyperhidrosis—Procarbazine—brain cancer	0.00188	0.00447	CcSEcCtD
Alprostadil—Renal failure—Carmustine—brain cancer	0.00187	0.00446	CcSEcCtD
Alprostadil—Hyperglycaemia—Temozolomide—brain cancer	0.00186	0.00443	CcSEcCtD
Alprostadil—Urinary tract infection—Carmustine—brain cancer	0.00185	0.00441	CcSEcCtD
Alprostadil—Erythema—Hydroxyurea—brain cancer	0.00184	0.00438	CcSEcCtD
Alprostadil—Cardiac arrest—Etoposide—brain cancer	0.00182	0.00433	CcSEcCtD
Alprostadil—Nausea—Lomustine—brain cancer	0.00182	0.00432	CcSEcCtD
Alprostadil—Hypotension—Procarbazine—brain cancer	0.00182	0.00432	CcSEcCtD
Alprostadil—Urinary tract infection—Temozolomide—brain cancer	0.00179	0.00426	CcSEcCtD
Alprostadil—Sinusitis—Temozolomide—brain cancer	0.00173	0.00411	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—MPL—brain cancer	0.00172	0.00562	CbGpPWpGaD
Alprostadil—Haemoglobin—Carmustine—brain cancer	0.00172	0.00409	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—PTCH2—brain cancer	0.00172	0.0056	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—PTCH2—brain cancer	0.00172	0.0056	CbGpPWpGaD
Alprostadil—Haemorrhage—Carmustine—brain cancer	0.00171	0.00407	CcSEcCtD
Alprostadil—Anaemia—Hydroxyurea—brain cancer	0.0017	0.00405	CcSEcCtD
Alprostadil—Hypoaesthesia—Carmustine—brain cancer	0.0017	0.00405	CcSEcCtD
Alprostadil—PTGER1—G alpha (q) signalling events—TRPC6—brain cancer	0.00169	0.00552	CbGpPWpGaD
Alprostadil—Haemoglobin—Temozolomide—brain cancer	0.00166	0.00395	CcSEcCtD
Alprostadil—Pain—Procarbazine—brain cancer	0.00166	0.00395	CcSEcCtD
Alprostadil—Haemorrhage—Temozolomide—brain cancer	0.00165	0.00393	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—S100A10—brain cancer	0.00165	0.00539	CbGpPWpGaD
Alprostadil—Visual impairment—Carmustine—brain cancer	0.00165	0.00392	CcSEcCtD
Alprostadil—Hypoaesthesia—Temozolomide—brain cancer	0.00165	0.00391	CcSEcCtD
Alprostadil—Pharyngitis—Temozolomide—brain cancer	0.00164	0.0039	CcSEcCtD
Alprostadil—Urethral disorder—Temozolomide—brain cancer	0.00162	0.00386	CcSEcCtD
Alprostadil—Sweating increased—Etoposide—brain cancer	0.00161	0.00383	CcSEcCtD
Alprostadil—Feeling abnormal—Procarbazine—brain cancer	0.0016	0.00381	CcSEcCtD
Alprostadil—Convulsion—Hydroxyurea—brain cancer	0.0016	0.0038	CcSEcCtD
Alprostadil—Visual impairment—Temozolomide—brain cancer	0.00159	0.00379	CcSEcCtD
Alprostadil—Flushing—Carmustine—brain cancer	0.00159	0.00378	CcSEcCtD
Alprostadil—Discomfort—Hydroxyurea—brain cancer	0.00155	0.00369	CcSEcCtD
Alprostadil—Body temperature increased—Procarbazine—brain cancer	0.00154	0.00365	CcSEcCtD
Alprostadil—Abdominal pain—Procarbazine—brain cancer	0.00154	0.00365	CcSEcCtD
Alprostadil—Flushing—Temozolomide—brain cancer	0.00153	0.00365	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.00151	0.00493	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—OR4C12—brain cancer	0.00151	0.00491	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—OR14C36—brain cancer	0.00151	0.00491	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—OR4C12—brain cancer	0.00151	0.00491	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—OR14C36—brain cancer	0.00151	0.00491	CbGpPWpGaD
Alprostadil—Oedema—Hydroxyurea—brain cancer	0.0015	0.00358	CcSEcCtD
Alprostadil—Infection—Hydroxyurea—brain cancer	0.00149	0.00355	CcSEcCtD
Alprostadil—Erythema—Carmustine—brain cancer	0.00149	0.00354	CcSEcCtD
Alprostadil—Thrombocytopenia—Hydroxyurea—brain cancer	0.00147	0.0035	CcSEcCtD
Alprostadil—Skin disorder—Hydroxyurea—brain cancer	0.00146	0.00347	CcSEcCtD
Alprostadil—Acute coronary syndrome—Etoposide—brain cancer	0.00145	0.00346	CcSEcCtD
Alprostadil—Renal failure—Etoposide—brain cancer	0.00145	0.00345	CcSEcCtD
Alprostadil—Myocardial infarction—Etoposide—brain cancer	0.00145	0.00344	CcSEcCtD
Alprostadil—Back pain—Carmustine—brain cancer	0.00144	0.00343	CcSEcCtD
Alprostadil—Erythema—Temozolomide—brain cancer	0.00144	0.00342	CcSEcCtD
Alprostadil—Asthenia—Procarbazine—brain cancer	0.00139	0.00332	CcSEcCtD
Alprostadil—Back pain—Temozolomide—brain cancer	0.00139	0.00331	CcSEcCtD
Alprostadil—Anaemia—Carmustine—brain cancer	0.00138	0.00327	CcSEcCtD
Alprostadil—Pruritus—Procarbazine—brain cancer	0.00137	0.00327	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—OR14C36—brain cancer	0.00137	0.00446	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—OR4C12—brain cancer	0.00137	0.00446	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—OR4C12—brain cancer	0.00137	0.00446	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—OR14C36—brain cancer	0.00137	0.00446	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—SHH—brain cancer	0.00133	0.00435	CbGpPWpGaD
Alprostadil—Anaemia—Temozolomide—brain cancer	0.00133	0.00316	CcSEcCtD
Alprostadil—Diarrhoea—Procarbazine—brain cancer	0.00133	0.00316	CcSEcCtD
Alprostadil—Dyspepsia—Hydroxyurea—brain cancer	0.00132	0.00315	CcSEcCtD
Alprostadil—Hypoaesthesia—Etoposide—brain cancer	0.00132	0.00313	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—SHH—brain cancer	0.00131	0.00427	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PTCH2—brain cancer	0.0013	0.00426	CbGpPWpGaD
Alprostadil—Urethral disorder—Etoposide—brain cancer	0.0013	0.00308	CcSEcCtD
Alprostadil—Convulsion—Carmustine—brain cancer	0.00129	0.00307	CcSEcCtD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00129	0.0042	CbGpPWpGaD
Alprostadil—Hypertension—Carmustine—brain cancer	0.00129	0.00306	CcSEcCtD
Alprostadil—Pain—Hydroxyurea—brain cancer	0.00129	0.00306	CcSEcCtD
Alprostadil—Dizziness—Procarbazine—brain cancer	0.00129	0.00306	CcSEcCtD
Alprostadil—Cough—Temozolomide—brain cancer	0.00126	0.00299	CcSEcCtD
Alprostadil—ABCC5—Fluoropyrimidine Activity—TP53—brain cancer	0.00125	0.00409	CbGpPWpGaD
Alprostadil—Convulsion—Temozolomide—brain cancer	0.00125	0.00297	CcSEcCtD
Alprostadil—Hypertension—Temozolomide—brain cancer	0.00124	0.00296	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—PTCH1—brain cancer	0.00124	0.00405	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—SMO—brain cancer	0.00124	0.00405	CbGpPWpGaD
Alprostadil—Feeling abnormal—Hydroxyurea—brain cancer	0.00124	0.00295	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—S100A10—brain cancer	0.00123	0.00401	CbGpPWpGaD
Alprostadil—Flushing—Etoposide—brain cancer	0.00123	0.00292	CcSEcCtD
Alprostadil—Rash—Procarbazine—brain cancer	0.00123	0.00291	CcSEcCtD
Alprostadil—Dermatitis—Procarbazine—brain cancer	0.00122	0.00291	CcSEcCtD
Alprostadil—Headache—Procarbazine—brain cancer	0.00122	0.0029	CcSEcCtD
Alprostadil—Oedema—Carmustine—brain cancer	0.00122	0.00289	CcSEcCtD
Alprostadil—Discomfort—Temozolomide—brain cancer	0.00121	0.00288	CcSEcCtD
Alprostadil—Infection—Carmustine—brain cancer	0.00121	0.00287	CcSEcCtD
Alprostadil—Dry mouth—Temozolomide—brain cancer	0.0012	0.00285	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—OR4C12—brain cancer	0.0012	0.0039	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—OR14C36—brain cancer	0.0012	0.0039	CbGpPWpGaD
Alprostadil—Thrombocytopenia—Carmustine—brain cancer	0.00119	0.00283	CcSEcCtD
Alprostadil—Body temperature increased—Hydroxyurea—brain cancer	0.00119	0.00283	CcSEcCtD
Alprostadil—Tachycardia—Carmustine—brain cancer	0.00119	0.00282	CcSEcCtD
Alprostadil—Oedema—Temozolomide—brain cancer	0.00118	0.00279	CcSEcCtD
Alprostadil—Infection—Temozolomide—brain cancer	0.00117	0.00278	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—BSG—brain cancer	0.00116	0.0038	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—ENO2—brain cancer	0.00116	0.00379	CbGpPWpGaD
Alprostadil—Nausea—Procarbazine—brain cancer	0.00115	0.00274	CcSEcCtD
Alprostadil—Thrombocytopenia—Temozolomide—brain cancer	0.00115	0.00274	CcSEcCtD
Alprostadil—Skin disorder—Temozolomide—brain cancer	0.00114	0.00271	CcSEcCtD
Alprostadil—Hypotension—Carmustine—brain cancer	0.00114	0.0027	CcSEcCtD
Alprostadil—PTGIR—Thromboxane A2 receptor signaling—EGFR—brain cancer	0.00114	0.00371	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Temozolomide—brain cancer	0.00114	0.0027	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—ABR—brain cancer	0.00113	0.00368	CbGpPWpGaD
Alprostadil—Back pain—Etoposide—brain cancer	0.00111	0.00265	CcSEcCtD
Alprostadil—Muscle spasms—Etoposide—brain cancer	0.00111	0.00263	CcSEcCtD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00108	0.00353	CbGpPWpGaD
Alprostadil—Asthenia—Hydroxyurea—brain cancer	0.00108	0.00257	CcSEcCtD
Alprostadil—Anaemia—Etoposide—brain cancer	0.00106	0.00253	CcSEcCtD
Alprostadil—Pain—Carmustine—brain cancer	0.00104	0.00247	CcSEcCtD
Alprostadil—Dyspepsia—Temozolomide—brain cancer	0.00103	0.00246	CcSEcCtD
Alprostadil—Diarrhoea—Hydroxyurea—brain cancer	0.00103	0.00245	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—MPL—brain cancer	0.00103	0.00335	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00102	0.00334	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—ABR—brain cancer	0.00102	0.00334	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—DTX2—brain cancer	0.00102	0.00332	CbGpPWpGaD
Alprostadil—Loss of consciousness—Etoposide—brain cancer	0.00101	0.00241	CcSEcCtD
Alprostadil—Cough—Etoposide—brain cancer	0.00101	0.00239	CcSEcCtD
Alprostadil—Pain—Temozolomide—brain cancer	0.001	0.00239	CcSEcCtD
Alprostadil—Feeling abnormal—Carmustine—brain cancer	0.001	0.00238	CcSEcCtD
Alprostadil—Convulsion—Etoposide—brain cancer	0.000998	0.00237	CcSEcCtD
Alprostadil—Hypertension—Etoposide—brain cancer	0.000995	0.00237	CcSEcCtD
Alprostadil—Dizziness—Hydroxyurea—brain cancer	0.000995	0.00237	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—S100A10—brain cancer	0.000984	0.00321	CbGpPWpGaD
Alprostadil—Discomfort—Etoposide—brain cancer	0.000969	0.0023	CcSEcCtD
Alprostadil—Feeling abnormal—Temozolomide—brain cancer	0.000968	0.0023	CcSEcCtD
Alprostadil—Abdominal pain—Carmustine—brain cancer	0.000961	0.00229	CcSEcCtD
Alprostadil—Body temperature increased—Carmustine—brain cancer	0.000961	0.00229	CcSEcCtD
Alprostadil—Rash—Hydroxyurea—brain cancer	0.000948	0.00226	CcSEcCtD
Alprostadil—Dermatitis—Hydroxyurea—brain cancer	0.000947	0.00225	CcSEcCtD
Alprostadil—Headache—Hydroxyurea—brain cancer	0.000942	0.00224	CcSEcCtD
Alprostadil—Infection—Etoposide—brain cancer	0.000934	0.00222	CcSEcCtD
Alprostadil—Body temperature increased—Temozolomide—brain cancer	0.000929	0.00221	CcSEcCtD
Alprostadil—Abdominal pain—Temozolomide—brain cancer	0.000929	0.00221	CcSEcCtD
Alprostadil—Thrombocytopenia—Etoposide—brain cancer	0.000921	0.00219	CcSEcCtD
Alprostadil—Tachycardia—Etoposide—brain cancer	0.000918	0.00218	CcSEcCtD
Alprostadil—Skin disorder—Etoposide—brain cancer	0.000913	0.00217	CcSEcCtD
Alprostadil—Hyperhidrosis—Etoposide—brain cancer	0.000909	0.00216	CcSEcCtD
Alprostadil—Nausea—Hydroxyurea—brain cancer	0.000893	0.00212	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—SHH—brain cancer	0.000884	0.00289	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—SHH—brain cancer	0.000884	0.00289	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000882	0.00288	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PTCH2—brain cancer	0.000881	0.00287	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTCH2—brain cancer	0.000881	0.00287	CbGpPWpGaD
Alprostadil—Hypotension—Etoposide—brain cancer	0.000879	0.00209	CcSEcCtD
Alprostadil—Asthenia—Carmustine—brain cancer	0.000872	0.00207	CcSEcCtD
Alprostadil—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	0.000868	0.00283	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000852	0.00278	CbGpPWpGaD
Alprostadil—ABCC5—Disease—DTX2—brain cancer	0.000843	0.00275	CbGpPWpGaD
Alprostadil—Asthenia—Temozolomide—brain cancer	0.000843	0.002	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—SMO—brain cancer	0.000838	0.00274	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—SMO—brain cancer	0.000838	0.00274	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—PTCH1—brain cancer	0.000838	0.00274	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—PTCH1—brain cancer	0.000838	0.00274	CbGpPWpGaD
Alprostadil—Diarrhoea—Carmustine—brain cancer	0.000832	0.00198	CcSEcCtD
Alprostadil—Pruritus—Temozolomide—brain cancer	0.000831	0.00198	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—OR4C12—brain cancer	0.000808	0.00263	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—OR14C36—brain cancer	0.000808	0.00263	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—OR14C36—brain cancer	0.000808	0.00263	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—OR4C12—brain cancer	0.000808	0.00263	CbGpPWpGaD
Alprostadil—Dizziness—Carmustine—brain cancer	0.000804	0.00191	CcSEcCtD
Alprostadil—Pain—Etoposide—brain cancer	0.000804	0.00191	CcSEcCtD
Alprostadil—Diarrhoea—Temozolomide—brain cancer	0.000804	0.00191	CcSEcCtD
Alprostadil—Dizziness—Temozolomide—brain cancer	0.000777	0.00185	CcSEcCtD
Alprostadil—Feeling abnormal—Etoposide—brain cancer	0.000775	0.00184	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—PTCH2—brain cancer	0.000771	0.00251	CbGpPWpGaD
Alprostadil—Rash—Carmustine—brain cancer	0.000767	0.00182	CcSEcCtD
Alprostadil—Dermatitis—Carmustine—brain cancer	0.000766	0.00182	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—TRPC6—brain cancer	0.000763	0.00249	CbGpPWpGaD
Alprostadil—Headache—Carmustine—brain cancer	0.000762	0.00181	CcSEcCtD
Alprostadil—PTGER1—GPCR downstream signaling—ABR—brain cancer	0.000761	0.00248	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—ABR—brain cancer	0.000761	0.00248	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HES5—brain cancer	0.000746	0.00243	CbGpPWpGaD
Alprostadil—Abdominal pain—Etoposide—brain cancer	0.000743	0.00177	CcSEcCtD
Alprostadil—Body temperature increased—Etoposide—brain cancer	0.000743	0.00177	CcSEcCtD
Alprostadil—Rash—Temozolomide—brain cancer	0.000741	0.00176	CcSEcCtD
Alprostadil—Dermatitis—Temozolomide—brain cancer	0.00074	0.00176	CcSEcCtD
Alprostadil—Headache—Temozolomide—brain cancer	0.000736	0.00175	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—STRADA—brain cancer	0.000724	0.00236	CbGpPWpGaD
Alprostadil—Nausea—Carmustine—brain cancer	0.000722	0.00172	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—TRPC6—brain cancer	0.000714	0.00233	CbGpPWpGaD
Alprostadil—Nausea—Temozolomide—brain cancer	0.000698	0.00166	CcSEcCtD
Alprostadil—ABCC4—Hemostasis—BSG—brain cancer	0.000694	0.00226	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—ABR—brain cancer	0.000691	0.00226	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—ABR—brain cancer	0.000691	0.00226	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DTX2—brain cancer	0.000687	0.00224	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DTX2—brain cancer	0.000687	0.00224	CbGpPWpGaD
Alprostadil—Asthenia—Etoposide—brain cancer	0.000675	0.0016	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—SHH—brain cancer	0.000672	0.00219	CbGpPWpGaD
Alprostadil—Pruritus—Etoposide—brain cancer	0.000665	0.00158	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000661	0.00216	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TRPC6—brain cancer	0.000648	0.00211	CbGpPWpGaD
Alprostadil—Diarrhoea—Etoposide—brain cancer	0.000643	0.00153	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—SMO—brain cancer	0.000637	0.00208	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PTCH1—brain cancer	0.000637	0.00208	CbGpPWpGaD
Alprostadil—Dizziness—Etoposide—brain cancer	0.000622	0.00148	CcSEcCtD
Alprostadil—ABCC5—Disease—HES5—brain cancer	0.000619	0.00202	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ABR—brain cancer	0.000605	0.00197	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000594	0.00194	CbGpPWpGaD
Alprostadil—Rash—Etoposide—brain cancer	0.000593	0.00141	CcSEcCtD
Alprostadil—Dermatitis—Etoposide—brain cancer	0.000592	0.00141	CcSEcCtD
Alprostadil—Headache—Etoposide—brain cancer	0.000589	0.0014	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—GLI2—brain cancer	0.000584	0.00191	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VAV1—brain cancer	0.000571	0.00186	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000568	0.00185	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—VEGFA—brain cancer	0.000566	0.00185	CbGpPWpGaD
Alprostadil—Nausea—Etoposide—brain cancer	0.000558	0.00133	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—GLI1—brain cancer	0.000549	0.00179	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	0.000539	0.00176	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—VAV1—brain cancer	0.000535	0.00174	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTCH2—brain cancer	0.00052	0.0017	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTCH2—brain cancer	0.00052	0.0017	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SUFU—brain cancer	0.00052	0.0017	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HES5—brain cancer	0.000504	0.00164	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HES5—brain cancer	0.000504	0.00164	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GFAP—brain cancer	0.000502	0.00164	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STRADA—brain cancer	0.000489	0.0016	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STRADA—brain cancer	0.000489	0.0016	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—VAV1—brain cancer	0.000485	0.00158	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—TRPC6—brain cancer	0.000482	0.00157	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—TRPC6—brain cancer	0.000482	0.00157	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2C9—brain cancer	0.000477	0.00156	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HEY1—brain cancer	0.000476	0.00155	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—DLL1—brain cancer	0.000467	0.00152	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TRPC6—brain cancer	0.000455	0.00148	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—SHH—brain cancer	0.000454	0.00148	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—SHH—brain cancer	0.000454	0.00148	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TRPC6—brain cancer	0.000438	0.00143	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TRPC6—brain cancer	0.000438	0.00143	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PTCH1—brain cancer	0.00043	0.0014	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—SMO—brain cancer	0.00043	0.0014	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—SMO—brain cancer	0.00043	0.0014	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTCH1—brain cancer	0.00043	0.0014	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.00042	0.00137	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IDH1—brain cancer	0.000417	0.00136	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	0.000415	0.00136	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ABR—brain cancer	0.000408	0.00133	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ABR—brain cancer	0.000408	0.00133	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—BSG—brain cancer	0.000406	0.00132	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SHH—brain cancer	0.000397	0.00129	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HEY1—brain cancer	0.000395	0.00129	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GLI2—brain cancer	0.000394	0.00129	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GLI2—brain cancer	0.000394	0.00129	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000394	0.00128	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000387	0.00126	CbGpPWpGaD
Alprostadil—ABCC5—Disease—DLL1—brain cancer	0.000387	0.00126	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TRPC6—brain cancer	0.000383	0.00125	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SMO—brain cancer	0.000376	0.00123	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTCH1—brain cancer	0.000376	0.00123	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GLI1—brain cancer	0.000371	0.00121	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GLI1—brain cancer	0.000371	0.00121	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—PIK3CG—brain cancer	0.000363	0.00118	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—VAV1—brain cancer	0.000361	0.00118	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—VAV1—brain cancer	0.000361	0.00118	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SUFU—brain cancer	0.000352	0.00115	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SUFU—brain cancer	0.000352	0.00115	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—IDH1—brain cancer	0.000349	0.00114	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VAV1—brain cancer	0.000341	0.00111	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—PIK3CG—brain cancer	0.000339	0.00111	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GFAP—brain cancer	0.000339	0.00111	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GFAP—brain cancer	0.000339	0.00111	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—MYC—brain cancer	0.000336	0.0011	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ENO2—brain cancer	0.000329	0.00107	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SHH—brain cancer	0.000329	0.00107	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—VAV1—brain cancer	0.000328	0.00107	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—VAV1—brain cancer	0.000328	0.00107	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HEY1—brain cancer	0.000322	0.00105	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HEY1—brain cancer	0.000322	0.00105	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DLL1—brain cancer	0.000315	0.00103	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DLL1—brain cancer	0.000315	0.00103	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PIK3CG—brain cancer	0.000308	0.00101	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOTCH2—brain cancer	0.000301	0.000981	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000295	0.000963	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VAV1—brain cancer	0.000287	0.000936	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ENO2—brain cancer	0.000276	0.0009	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SHH—brain cancer	0.000268	0.000875	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SHH—brain cancer	0.000268	0.000875	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TRPC6—brain cancer	0.000259	0.000843	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TRPC6—brain cancer	0.000259	0.000843	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IL2—brain cancer	0.000255	0.000833	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SMO—brain cancer	0.000254	0.000829	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SMO—brain cancer	0.000254	0.000829	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTCH1—brain cancer	0.000254	0.000829	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTCH1—brain cancer	0.000254	0.000829	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000251	0.000819	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HES1—brain cancer	0.000247	0.000805	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—IL2—brain cancer	0.000239	0.000779	CbGpPWpGaD
Alprostadil—ABCC5—Disease—VAV1—brain cancer	0.000238	0.000776	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PDGFRA—brain cancer	0.000235	0.000766	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CG—brain cancer	0.000229	0.000748	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CG—brain cancer	0.000229	0.000748	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SPP1—brain cancer	0.000228	0.000744	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—brain cancer	0.000217	0.000708	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL2—brain cancer	0.000217	0.000708	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CG—brain cancer	0.000216	0.000705	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CG—brain cancer	0.000208	0.000679	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CG—brain cancer	0.000208	0.000679	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IRS2—brain cancer	0.000206	0.000673	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HES1—brain cancer	0.000205	0.000667	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH2—brain cancer	0.000203	0.000663	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH2—brain cancer	0.000203	0.000663	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PDGFRA—brain cancer	0.000195	0.000635	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VAV1—brain cancer	0.000194	0.000632	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VAV1—brain cancer	0.000194	0.000632	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CG—brain cancer	0.000182	0.000594	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APC—brain cancer	0.000182	0.000594	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IRS2—brain cancer	0.000171	0.000558	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HES1—brain cancer	0.000167	0.000544	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HES1—brain cancer	0.000167	0.000544	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EGFR—brain cancer	0.000166	0.000541	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—brain cancer	0.000164	0.000535	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—IL2—brain cancer	0.000161	0.000526	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—IL2—brain cancer	0.000161	0.000526	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDGFRA—brain cancer	0.000159	0.000517	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDGFRA—brain cancer	0.000159	0.000517	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SPP1—brain cancer	0.000154	0.000502	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SPP1—brain cancer	0.000154	0.000502	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IL2—brain cancer	0.000152	0.000496	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APC—brain cancer	0.000151	0.000493	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL2—brain cancer	0.000147	0.000478	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL2—brain cancer	0.000147	0.000478	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RELA—brain cancer	0.000142	0.000464	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ERBB2—brain cancer	0.000141	0.000461	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IRS2—brain cancer	0.000139	0.000454	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IRS2—brain cancer	0.000139	0.000454	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—brain cancer	0.000129	0.000422	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL2—brain cancer	0.000128	0.000418	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CG—brain cancer	0.000126	0.000413	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCND1—brain cancer	0.000125	0.000408	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CTNNB1—brain cancer	0.000124	0.000404	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APC—brain cancer	0.000123	0.000401	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APC—brain cancer	0.000123	0.000401	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CG—brain cancer	0.000123	0.000401	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CG—brain cancer	0.000123	0.000401	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ERBB2—brain cancer	0.000117	0.000383	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EGFR—brain cancer	0.000112	0.000366	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EGFR—brain cancer	0.000112	0.000366	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—brain cancer	0.000109	0.000355	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—STAT3—brain cancer	0.000108	0.000352	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CTNNB1—brain cancer	0.000103	0.000335	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MYC—brain cancer	0.0001	0.000327	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EGFR—brain cancer	9.8e-05	0.00032	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—brain cancer	9.77e-05	0.000319	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RELA—brain cancer	9.61e-05	0.000314	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RELA—brain cancer	9.61e-05	0.000314	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ERBB2—brain cancer	9.55e-05	0.000312	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ERBB2—brain cancer	9.55e-05	0.000312	CbGpPWpGaD
Alprostadil—ABCC5—Disease—STAT3—brain cancer	8.94e-05	0.000292	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL2—brain cancer	8.66e-05	0.000282	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL2—brain cancer	8.66e-05	0.000282	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCND1—brain cancer	8.44e-05	0.000275	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCND1—brain cancer	8.44e-05	0.000275	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CTNNB1—brain cancer	8.36e-05	0.000273	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CTNNB1—brain cancer	8.36e-05	0.000273	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MYC—brain cancer	8.31e-05	0.000271	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—brain cancer	8.23e-05	0.000268	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EGFR—brain cancer	8.13e-05	0.000265	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—brain cancer	7.36e-05	0.00024	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—brain cancer	7.36e-05	0.00024	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT3—brain cancer	7.28e-05	0.000238	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT3—brain cancer	7.28e-05	0.000238	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MYC—brain cancer	6.77e-05	0.000221	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MYC—brain cancer	6.77e-05	0.000221	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EGFR—brain cancer	6.62e-05	0.000216	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EGFR—brain cancer	6.62e-05	0.000216	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—brain cancer	5.56e-05	0.000181	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—brain cancer	5.56e-05	0.000181	CbGpPWpGaD
